Additionally, the DEB‐TACE group achieved enhanced TTP compared to the cTACE group, particularly among patients aged ≥50 years and those with characteristics such as hepatitis B virus infection, AFP levels ≥200 ng/mL, multiple intrahepatic tumors, PVTT, extrahepatic metastasis, and pre‐TACE TBil levels >99 μmol/L, as shown in Figure 5B. This evidence concerns the gene AFP and hepatitis B virus infection.